Suze Orman Warns Americans Underestimate Critical Retirement Healthcare Cost Diversified Energy Expands Permian Basin Footprint With Maverick Acquisition HELOC and Home Equity Loan Rates May 24 2026 Truist Named Best Lender Amidst Competitive Rates IndoStar Capital Reports 130 Crore Annual Profit Q4 Loss Widens to 424 Crore on Higher Provisions for Legacy Security Receipts Berkshire Hathaway Revives Airline Bet with 26 Billion Stake in Delta Air Lines ET Alpha Wealth Summit to Address Portfolio Resilience and Alpha Generation in Mumbai AMTB Q1 2026 Earnings EPS Slightly Below Estimates Shares Edge Higher AdaptHealth Corp AHCO Q1 2026 Earnings EPS Misses Estimates by a Wide Margin WIMI Q4 2020 Earnings EPS Misses Estimates Amid Slight Stock Decline ARR Q1 2026 Earnings EPS Beats Estimates as Portfolio Strategy Offsets Market Pressure AMCX Q1 2026 Earnings EPS Falls Short of Estimates as Stock Gains 267 CEPU Q4 2024 Earnings Steep EPS Miss Pressures Shares as Argentine Headwinds Intensify Custom Truck One Source CTOS Rallies 118 as Stock Approaches Key Resistance One Liberty Properties Inc OLP Slips Slightly as Real Estate Sector Faces Headwinds Roadzen Warrants RDZNW Surge 23 Momentum Builds Above Key Support Provident Financial Holdings PROV Posts Modest Gain as Stock Holds Above Support SnapOn SNA Holds Steady Near Support as Sector Awaits Catalysts Chinas Humanoid Robot Ambitions Signal Intensifying Global Competition Says Teslas Musk TGT Q1 2026 Earnings EPS of 171 Highlights Resilient Operations Amid Modest Stock Decline WaFd Inc Depositary Shares WAFDP Edges Higher as Support Holds HERE Q4 2025 Earnings EPS Surges Over 1150 Above Estimates Yet Shares Dip elf Beauty ELF Q1 2026 Earnings EPS Beats Estimates Amid Solid Execution Nvidias Record Earnings Report Faces Investor Skepticism Over Growth Sustainability Barclays Raises Price Target on JFrog to 75 Maintains Overweight Rating IonQ Q1 2026 Earnings EPS Surprise Beats Estimates as Stock Jumps 12 FEED Q1 2026 Earnings Significant Loss Per Share Reported Stock Edges Lower Trevi Therapeutics Q1 2026 Earnings Narrowing Losses but Trial Failures Weigh on Sentiment